Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
The report details the trend, potential and market size of Peptide Based Gastrointestinal Disorders Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Based Gastrointestinal Disorders Therapeuticsmarket, defines the market attractiveness level of Peptide Based Gastrointestinal Disorders Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Based Gastrointestinal Disorders Therapeutics industry, describes the types of Peptide Based Gastrointestinal Disorders Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Based Gastrointestinal Disorders Therapeutics market and the development prospects and opportunities of Peptide Based Gastrointestinal Disorders Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Based Gastrointestinal Disorders Therapeutics market in Chapter 13.
By Player:
Allergan plc
NPS Pharmaceuticals, Inc
Ironwood Pharmaceuticals, Inc
Astellas Pharma Inc
Cipher Pharmaceuticals Inc
Synergy Pharmaceuticals Inc
By Type:
Teduglutide
Linaclotide
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Based Gastrointestinal Disorders Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Based Gastrointestinal Disorders Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Based Gastrointestinal Disorders Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.2 United States Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.4 China Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.5 Japan Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.6 India Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
-
7.7 South Korea Peptide Based Gastrointestinal Disorders Therapeutics Consumption (2017-2022)
8 Region and Country-wise Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast (2022-2028)
9 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Teduglutide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Linaclotide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Teduglutide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Based Gastrointestinal Disorders Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Competitive Analysis
-
14.1 Allergan plc
-
14.1.1 Allergan plc Company Details
-
14.1.2 Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
14.2 NPS Pharmaceuticals, Inc
-
14.2.1 NPS Pharmaceuticals, Inc Company Details
-
14.2.2 NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
14.3 Ironwood Pharmaceuticals, Inc
-
14.3.1 Ironwood Pharmaceuticals, Inc Company Details
-
14.3.2 Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
14.4 Astellas Pharma Inc
-
14.4.1 Astellas Pharma Inc Company Details
-
14.4.2 Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
14.5 Cipher Pharmaceuticals Inc
-
14.5.1 Cipher Pharmaceuticals Inc Company Details
-
14.5.2 Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
14.6 Synergy Pharmaceuticals Inc
-
14.6.1 Synergy Pharmaceuticals Inc Company Details
-
14.6.2 Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Based Gastrointestinal Disorders Therapeutics
-
Figure Peptide Based Gastrointestinal Disorders Therapeutics Picture
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Country (2017-2022)
-
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Teduglutide Consumption and Growth Rate (2017-2022)
-
Figure Global Linaclotide Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Teduglutide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
Table NPS Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
Table Ironwood Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
Table Cipher Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
Table Synergy Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product and Service
-
